Plus Therapeutics, Inc. (PSTV)
NASDAQ: PSTV · Real-Time Price · USD
0.2025
0.00 (0.00%)
At close: Jun 18, 2025, 4:00 PM
0.2070
+0.0045 (2.22%)
Pre-market: Jun 20, 2025, 8:05 AM EDT

Plus Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2015 - 2019
Period Ending
Mar '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2015 - 2019
Revenue
5.215.824.910.22-0.3
Upgrade
Revenue Growth (YoY)
-14.43%18.54%2093.30%---95.67%
Upgrade
Cost of Revenue
9.5710.589.699.75.322.7
Upgrade
Gross Profit
-4.37-4.76-4.78-9.47-5.32-2.4
Upgrade
Selling, General & Admin
10.579.948.5410.246.856.41
Upgrade
Operating Expenses
10.579.948.5410.246.856.41
Upgrade
Operating Income
-14.93-14.7-13.32-19.71-12.18-8.8
Upgrade
Interest Expense
-3.9-0.18-0.4-0.71-0.93-1.11
Upgrade
Interest & Investment Income
0.20.270.40.150.020.05
Upgrade
Other Non Operating Income (Expenses)
-8.481.62-00.012.4
Upgrade
EBT Excluding Unusual Items
-27.12-12.98-13.32-20.28-13.08-7.46
Upgrade
Gain (Loss) on Sale of Assets
-----0.07-
Upgrade
Pretax Income
-27.12-12.98-13.32-20.28-13.4-8.24
Upgrade
Earnings From Continuing Operations
-27.12-12.98-13.32-20.28-13.4-8.24
Upgrade
Net Income
-27.12-12.98-13.32-20.28-13.4-8.24
Upgrade
Net Income to Common
-27.12-12.98-13.32-20.28-13.4-8.24
Upgrade
Shares Outstanding (Basic)
973210
Upgrade
Shares Outstanding (Diluted)
983210
Upgrade
Shares Change (YoY)
152.69%145.18%79.45%117.18%173.03%219.93%
Upgrade
EPS (Basic)
-2.95-1.95-4.24-11.58-16.63-27.92
Upgrade
EPS (Diluted)
-3.50-2.34-4.24-11.58-16.65-27.92
Upgrade
Free Cash Flow
-12.32-10.7-13.01-13.48-10.42-8.53
Upgrade
Free Cash Flow Per Share
-1.34-1.39-4.14-7.70-12.93-28.89
Upgrade
Gross Margin
-83.88%-81.66%-97.23%---
Upgrade
Operating Margin
-286.82%-252.32%-271.14%-8800.00%--2905.28%
Upgrade
Profit Margin
-520.90%-222.84%-271.04%-9051.34%--2719.80%
Upgrade
Free Cash Flow Margin
-236.69%-183.72%-264.83%-6018.30%--2814.19%
Upgrade
EBITDA
-14.22-13.97-12.69-19.09-11.78-8.44
Upgrade
EBITDA Margin
-273.11%-239.90%-258.35%---
Upgrade
D&A For EBITDA
0.710.720.630.620.40.37
Upgrade
EBIT
-14.93-14.7-13.32-19.71-12.18-8.8
Upgrade
EBIT Margin
-286.82%-252.32%-271.14%---
Upgrade
Revenue as Reported
-----0.3
Upgrade
Updated Mar 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q